Tommy G. Thompson - 28 Feb 2023 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role: Director
Signature: /s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol: UTHR
Transactions as of: 28 Feb 2023
Net transactions value: -$455,350
Form type: 4
Filing time: 01 Mar 2023, 15:30:51 UTC
Previous filing: 17 Jan 2023
Next filing: 03 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	UTHR	Common Stock	Options Exercise	$159,750	+2,500	+33%	$63.90	10,100	28 Feb 2023	Direct	F1
transaction	UTHR	Common Stock	Disposed to Issuer	$615,100	-2,500	-25%	$246.04	7,600	28 Mar 2023	Direct	F1
holding	UTHR	Common Stock						5,800	28 Feb 2023	Family LLC
holding	UTHR	Common Stock						8,200	28 Feb 2023	Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	UTHR	Share Tracking Award	Options Exercise	$0	-2,500	-25%	$0.000000	7,500	28 Feb 2023	Common Stock	2,500	$63.90	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Exercise of share tracking awards set to expire 6/25/2023. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.